Moss Vivaldi
66 posts

Moss Vivaldi
@VivaldiBham
We are a viral immunology group part of the Moss lab at @unibirmingham. Our current focus is the impact of SARS-CoV-2 and vaccinations in LTCFs









@jmzuo73 @ShamezLadhani @AlexD_81 @VivaldiBham @Meg_Butler96 @paulmos63832199 What about the ones it isn’t mild for? And how can you be sure that infections are ‘mild’ without considering the hidden health impacts, such as blood vessel damage? Unless we’re following up on every infected child, nobody can possibly know how mild this is to children yet.

Exciting day! Omicron antibody test working beautifully - waning at 6 months post 2nd dose but 3rd dose booster post AZ or Pfizer - brilliant levels against omicron. True for a haemodialysis population too. Booster strategy looks sound @sfaustini @immunologydoc @BanhamGemma





when #GUpath experts meet to discuss diagnosis & grading of prostatic intraductal carcinoma twitter.com/Drunkenfight_/…

Sharing some potentially significant findings relating to Omicron given the current situation. First of all huge thanks to the team working flat out- Bo Meng, @isabella_atmf and to our collaborators both in G2P, J2P along with @SystemsVirology. Findings as follows:







